BioXcel Therapeutics
BTAI
#10063
Rank
$9.78 M
Marketcap
$1.79
Share price
5.92%
Change (1 day)
-96.23%
Change (1 year)

BioXcel Therapeutics (BTAI) - Cash on Hand

Cash on Hand as of December 2024 : $29.85 Million USD

According to BioXcel Therapeutics's latest financial reports the company has $29.85 Million USD in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

BioXcel Therapeutics - Cash on Hand chart (from 2017 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31$65.22 M-66.33%
2022-12-31$0.19 B-16.84%
2021-12-31$0.23 B9.31%
2020-12-31$0.21 B557.25%
2019-12-31$32.42 M-23.82%
2018-12-31$42.56 M4698.76%
2017-12-31$0.88 M
2016-12-31N/A

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
$0.25 B 757.37%๐Ÿ‡บ๐Ÿ‡ธ USA